BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/10/2022 5:40:20 AM | Browse: 769 | Download: 1731
 |
Received |
|
2022-02-16 17:36 |
|
Peer-Review Started |
|
2022-02-16 17:39 |
|
First Decision by Editorial Office Director |
|
2022-03-09 01:17 |
|
Return for Revision |
|
2022-03-09 01:17 |
|
Revised |
|
2022-03-22 14:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-04-15 02:03 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-04-15 21:03 |
|
Articles in Press |
|
2022-04-15 21:03 |
|
Edit the Manuscript by Language Editor |
|
2022-04-27 17:00 |
|
Typeset the Manuscript |
|
2022-05-30 07:10 |
|
Publish the Manuscript Online |
|
2022-06-10 05:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ester Badami, Rosalia Busà, Bruno Douradinha, Giovanna Russelli, Vitale Miceli, Alessia Gallo, Giovanni Zito, Pier Giulio Conaldi and Gioacchin Iannolo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gioacchin Iannolo, BSc, PhD, Research Scientist, Department of Research, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS-ISMETT), Via E. Tricomi 5, Palermo 90127, Italy. giannolo@ismett.edu |
| Key Words |
Hepatocellular carcinoma; miRNA; Liver; Hepatitis C virus; miRNAs; Direct-acting antivirals; Extracellular vesicles; Transplantation |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the most life-threatening cancers in the world. Among other factors, HCC is frequently caused by chronic hepatitis C virus infection. Currently, the mechanisms responsible for its neoplastic transformation are not completely understood. Regardless of the recent discovery and therapeutic use of latest-generation direct-acting antivirals, HCC remains an unsolved problem, even after viral eradication. In this scenario, miRNAs can become both a diagnostic tool and, hopefully, a novel therapeutic approach. |
| Publish Date |
2022-06-10 05:40 |
| Citation |
Badami E, Busà R, Douradinha B, Russelli G, Miceli V, Gallo A, Zito G, Conaldi PG, Iannolo G. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World J Gastroenterol 2022; 28(22): 2417-2428 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i22/2417.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i22.2417 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
